| An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice (NCT01498900) | Novo Nordisk A/S | 2004-08-01 |
| Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes (NCT00593255) | Novo Nordisk A/S | 2004-07-01 |
| Use of Activated Recombinant FVII in Spinal Surgery (NCT00102037) | Novo Nordisk A/S | 2004-07-01 |
| NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes (NCT00095446) | Novo Nordisk A/S | 2004-07-01 |
| Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes (NCT00564668) | Novo Nordisk A/S | 2004-06-19 |
| Observational Study to Evaluate the Safety of Levemir® in Diabetes (NCT00659295) | Novo Nordisk A/S | 2004-06-01 |
| Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes (NCT00184665) | Novo Nordisk A/S | 2004-06-01 |
| Dose Response to Recombinant Factor VIIa When Administered for Bleed (NCT00104455) | Novo Nordisk A/S | 2004-06-01 |
| Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations (NCT00184795) | Novo Nordisk A/S | 2004-05-28 |
| Comparison of Two Liraglutide Formulations in Healthy Volunteers (NCT01508897) | Novo Nordisk A/S | 2004-05-28 |
| Within-subject Variability of Insulin Detemir in Healthy Volunteers (NCT01497535) | Novo Nordisk A/S | 2004-05-27 |
| Safety of Insulin Detemir in Children With Type 1 Diabetes (NCT00605137) | Novo Nordisk A/S | 2004-05-21 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes (NCT00624364) | Novo Nordisk A/S | 2004-05-01 |
| Use of NovoSeven® in Active Variceal Bleeding (NCT00154492) | Novo Nordisk A/S | 2004-04-01 |
| Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes (NCT00592527) | Novo Nordisk A/S | 2004-04-01 |
| Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers (NCT01507337) | Novo Nordisk A/S | 2004-04-01 |
| Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia (NCT00760448) | Novo Nordisk A/S | 2004-04-01 |
| Observational Study With InnoLet® in Daily Clinical Practice (NCT01492959) | Novo Nordisk A/S | 2004-03-23 |
| Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction (NCT01492218) | Novo Nordisk A/S | 2004-03-15 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes (NCT00600366) | Novo Nordisk A/S | 2004-03-01 |
| Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia (NCT00108758) | Novo Nordisk A/S | 2004-03-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (NCT01497600) | Novo Nordisk A/S | 2004-02-01 |
| Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes (NCT00600626) | Novo Nordisk A/S | 2004-01-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus (NCT01542060) | Novo Nordisk A/S | 2004-01-01 |
| Observational Registry of the Treatment of Glanzmann's Thrombasthenia (NCT01476423) | Novo Nordisk A/S | 2004-01-01 |
| Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes (NCT00568074) | Novo Nordisk A/S | 2003-12-16 |
| Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) (NCT00184743) | Novo Nordisk A/S | 2003-12-06 |
| Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT00592969) | Novo Nordisk A/S | 2003-12-03 |
| Efficacy and Safety of Insulin Detemir in Type 1 Diabetes (NCT00595374) | Novo Nordisk A/S | 2003-12-02 |
| Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT00605020) | Novo Nordisk A/S | 2003-12-02 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes (NCT00619697) | Novo Nordisk A/S | 2003-12-01 |
| Paediatric Subjects - Special Survey (NCT01538576) | Novo Nordisk A/S | 2003-12-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes (NCT00605111) | Novo Nordisk A/S | 2003-12-01 |
| Special Survey for Patients With Type 1 or Type 2 Diabetes (NCT01538589) | Novo Nordisk A/S | 2003-12-01 |
| Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes (NCT01615978) | Novo Nordisk A/S | 2003-12-01 |
| Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone (NCT00604253) | Novo Nordisk A/S | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects (NCT01527656) | Novo Nordisk A/S | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects (NCT01620437) | Novo Nordisk A/S | 2003-11-29 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects (NCT01527643) | Novo Nordisk A/S | 2003-11-11 |
| Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00280046) | Novo Nordisk A/S | 2003-11-01 |
| Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes (NCT00799448) | Novo Nordisk A/S | 2003-09-16 |
| Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes (NCT00612599) | Novo Nordisk A/S | 2003-09-01 |
| Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers (NCT01620476) | Novo Nordisk A/S | 2003-09-01 |
| Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin (NCT00569998) | Novo Nordisk A/S | 2003-08-01 |
| Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes (NCT00571935) | Novo Nordisk A/S | 2003-08-01 |
| Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age (NCT00557336) | Novo Nordisk A/S | 2003-07-28 |
| French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin (NCT01580605) | Novo Nordisk A/S | 2003-07-17 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes (NCT00617565) | Novo Nordisk A/S | 2003-07-08 |
| Safety and Efficacy of Long-term Somatropin Treatment in Adults (NCT01543880) | Novo Nordisk A/S | 2003-07-01 |
| An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime (NCT01487421) | Novo Nordisk A/S | 2003-07-01 |
| Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs (NCT00791895) | Novo Nordisk A/S | 2003-06-26 |
| Growth Hormone Deficiency in Adults (GHDA) (NCT00519558) | Novo Nordisk A/S | 2003-05-31 |
| Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes (NCT00604656) | Novo Nordisk A/S | 2003-05-05 |
| Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children (NCT00102817) | Novo Nordisk A/S | 2003-05-01 |
| Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers (NCT01848002) | Novo Nordisk A/S | 2003-05-01 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes (NCT00569400) | Novo Nordisk A/S | 2003-05-01 |
| Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes (NCT00604344) | Novo Nordisk A/S | 2003-04-01 |
| Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease (NCT00184652) | Novo Nordisk A/S | 2003-04-01 |
| Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women (NCT00560924) | Novo Nordisk A/S | 2003-03-21 |
| Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT00567385) | Novo Nordisk A/S | 2003-03-10 |
| Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency (NCT00056589) | Novo Nordisk A/S | 2003-03-01 |
| Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (NCT01497561) | Novo Nordisk A/S | 2003-03-01 |
| Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes (NCT00604396) | Novo Nordisk A/S | 2003-03-01 |
| Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes (NCT00283751) | Novo Nordisk A/S | 2003-03-01 |
| NovoLet® Surveillance Study on Using Human Insulin System in Indonesia (NCT01492153) | Novo Nordisk A/S | 2003-02-11 |
| Initiation of Insulin Aspart in Type 2 Diabetes (NCT00572806) | Novo Nordisk A/S | 2003-02-05 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects (NCT01527565) | Novo Nordisk A/S | 2003-01-20 |
| Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process (NCT01486914) | Novo Nordisk A/S | 2003-01-19 |
| Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers (NCT01847989) | Novo Nordisk A/S | 2003-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers (NCT01620463) | Novo Nordisk A/S | 2002-12-01 |
| Comparison of Glycemic Control Achieved With 2 Different Needles (NCT00572052) | Novo Nordisk A/S | 2002-12-01 |
| Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes (NCT00568984) | Novo Nordisk A/S | 2002-11-21 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects (NCT01527630) | Novo Nordisk A/S | 2002-11-16 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects (NCT01527552) | Novo Nordisk A/S | 2002-11-05 |
| High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors (NCT00571584) | Novo Nordisk A/S | 2002-11-01 |
| Efficacy on Height in SGA Children Treated With Growth Hormone (NCT00184756) | Novo Nordisk A/S | 2002-11-01 |
| Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy (NCT00598793) | Novo Nordisk A/S | 2002-11-01 |
| Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes (NCT00567775) | Novo Nordisk A/S | 2002-10-21 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers (NCT01448070) | Novo Nordisk A/S | 2002-10-15 |
| Human Insulin NPH and Insulin Aspart in Type 1 Diabetes (NCT00597233) | Novo Nordisk A/S | 2002-10-01 |
| Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes (NCT01720303) | Novo Nordisk A/S | 2002-09-19 |
| Comparison of Two Insulin Aspart Formulations in Healthy Volunteers (NCT01698697) | Novo Nordisk A/S | 2002-09-02 |
| Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes (NCT00725036) | Novo Nordisk A/S | 2002-09-02 |
| Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction (NCT01601457) | Novo Nordisk A/S | 2002-09-01 |
| Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes (NCT00365170) | Novo Nordisk A/S | 2002-09-01 |
| Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State (NCT01562587) | Novo Nordisk A/S | 2002-09-01 |
| Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes (NCT01467401) | Novo Nordisk A/S | 2002-08-19 |
| Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (NCT00426803) | Novo Nordisk A/S | 2002-08-01 |
| Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes (NCT00312156) | Novo Nordisk A/S | 2002-08-01 |
| Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes (NCT01511172) | Novo Nordisk A/S | 2002-08-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes (NCT01542450) | Novo Nordisk A/S | 2002-08-01 |
| Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes (NCT01720290) | Novo Nordisk A/S | 2002-07-25 |
| Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01697631) | Novo Nordisk A/S | 2002-07-22 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation (NCT01564563) | Novo Nordisk A/S | 2002-06-28 |
| An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) (NCT01009905) | Novo Nordisk A/S | 2002-06-24 |
| Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes (NCT01467141) | Novo Nordisk A/S | 2002-06-19 |
| Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population (NCT00071448) | Novo Nordisk A/S | 2002-06-01 |
| Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01487798) | Novo Nordisk A/S | 2002-06-01 |
| Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes (NCT01526980) | Novo Nordisk A/S | 2002-05-01 |
| Efficacy of Repaglinide in Subjects With Type 2 Diabetes (NCT01698931) | Novo Nordisk A/S | 2002-04-26 |